The Future of Swedish & Danish Life Science Date: Wednesday April 8, 2015 Place: Medicon Village, Scheelevägen 2, Lund In an era of change – how will the actors enter the new Life Science scene? Moderator: he feasibility study is key to success in T your clinical trial N igel Jones, TFS Lucy Robertshaw, International Business Development Consultant Thriving in the new health economy Sarah Lidé, PwC Do experts in ‘small’ molecule synthesis really need new technology? Anders Bøgevig, Chemnotia AB Working together for better health and well-being – how is it done/what is the model? Kerstin Jakobsson, Medicon Village Social media: an essential enabler for collaboration and growth Andrew Hennigan, communication consultant, business school lecturer and freelance journalist Trends in talent attraction – a global fight Tina Persson, professional academic career advisor Aseptic processing in modern biological manufacture Mattias Nordlander, Cobra Biologics Delivery of b iologics: Successes and challenges in the treatment of diabetes Tomas Landh, Novo Nordisk SWElife: Accelerating innovation and collaborative processes in Swedish Life Science Peter Nordström, Peter Nordström, SWElife Drug development planning in early projects Anna Törner, Scandinavian Nanotechnology facility to Lund Yvonne Mårtensson, Nanova Development Services (SDS) For more info and registration go to www.swedishdanishlifescience.se ORGANIZER: MAIN PARTNER: PARTNERS: